Market Overview:
The global inhaler devices market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of respiratory diseases, growing geriatric population, and technological advancements in inhaler devices. Based on type, the global inhaler devices market is segmented into metered dose inhalers (MDIs), dry powder inhalers (DPIs), and soft mist inhalers (SMIs). MDIs are further sub-segmented into pressurized metered dose inhalers (pMDIs) and non-pressurized metered dose inhalers (nMDIs). DPIs are further sub-segmented into single drug DPIS and combination drug DPIS. SMIs are further sub-segmented into ultrasonic nebulizers and vibrating mesh nebulizers. Based on application, the global market is segmented into adults and children. Adults are further divided into chronic obstructive pulmonary disease (COPD) patients, asthma patients, bronchitis patients, pneumonia patients, cystic fibrosis patients; while children are subdivided as those below 5 years of age and those aged between 5–18 years old. Geographically, the global market is segmentedinto North America,, Europe,, Asia Pacific,,and Middle East & Africa .
Product Definition:
An inhaler is a medical device that delivers medication to the lungs in the form of a mist, which is inhaled. Inhalers are used to treat conditions such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis.
Metered Dose Inhaler (MDI):
MDI is a device used to inhale drugs by the mouth. It's an alternative to traditional methods of drug delivery such as syringes and vials. MDI has been around for quite some time, but its growth factor in inhaler devices market was observed only recently due to increasing prevalence of chronic respiratory diseases such as asthma, COPD and Chronic Obstructive Pulmonary Disease (COPD).
Dry Powder Inhaler (DPI):
Dry powder inhaler (DPI) is a device used to deliver dry powder medication through an inhalation therapy. The most common type of dry powders are the nebulizers, which produce a mixture of gases such as oxygen and water vapor that are then inhaled by the patient. DPI’s work in much the same way as nebulizers; however, they do not require any liquid to be added along with it for its operation.
Application Insights:
The adults segment held the largest share of 60.0% in 2017 owing to the high usage of inhalers for asthma treatment among adults. Asthma is a chronic lung disease which affects approximately 40 million people in U.S., Canada and Europe, accounting for around 4% to 5% of total population.
Regional Analysis:
North America dominated the global market in 2017 owing to favorable reimbursement policies, high awareness levels about asthma management, and presence of major players. In addition, increasing prevalence of respiratory diseases is also expected to drive the demand for inhaler devices in this region. According to data published by CDC’s National Center for Health Statistics (NCHS), between 2010 and 2015 around 18% increase was observed in the number of adults with asthma. Moreover, an estimated 6 million children under 18 years had asthma in 2014 which is approximately 4% increase from 2011.
Asia Pacific is expected to witness lucrative growth over the forecast period due as a result of rising disposable income coupled with growing target population base especially among geriatric population group that requires long-term treatment for their chronic respiratory conditions such as COPD or asthma.
Growth Factors:
- Increasing prevalence of respiratory diseases: The global inhaler devices market is expected to grow at a CAGR of 5.5% during the forecast period due to the increasing prevalence of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and tuberculosis. Inhalers are used for the treatment of these diseases and help in relieving symptoms such as shortness of breath, chest tightness, wheezing, and coughing.
- Technological advancements: The development of novel inhaler devices with advanced features is one of the key growth drivers for this market. These devices offer better patient compliance owing to their easy-to-use designs and enhanced performance characteristics such as dose delivery accuracy and reduced side effects.
- Growing demand from emerging markets: The demand for inhaler devices is growing rapidly in emerging markets due to the increasing awareness about their benefits among patients and healthcare professionals alike. Additionally, rising income levels are enabling more people in these regions to afford expensive therapies that require use of inhalers Devices market . This is likely to result in significant growth opportunities for players operating in this market over the next few years..
Scope Of The Report
Report Attributes
Report Details
Report Title
Inhaler Devices Market Research Report
By Type
Metered Dose Inhaler (MDI), Dry Powder Inhaler (DPI), Soft Mist Inhaler (SMI)
By Application
Adults, Children
By Companies
3M, Bespak, Gerresheimer AG, Hovione, Iconovo AB, Adherium, Cohero Health, Trudell Medical International, Beximco Pharmaceuticals Ltd, Boehringer Ingelheim GmbH, Cipla Ltd, GSK, PARI Medical Holding, Teva Pharmaceutical Industries Ltd
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
230
Number of Tables & Figures
161
Customization Available
Yes, the report can be customized as per your need.
Global Inhaler Devices Market Report Segments:
The global Inhaler Devices market is segmented on the basis of:
Types
Metered Dose Inhaler (MDI), Dry Powder Inhaler (DPI), Soft Mist Inhaler (SMI)
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Adults, Children
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- 3M
- Bespak
- Gerresheimer AG
- Hovione
- Iconovo AB
- Adherium
- Cohero Health
- Trudell Medical International
- Beximco Pharmaceuticals Ltd
- Boehringer Ingelheim GmbH
- Cipla Ltd
- GSK
- PARI Medical Holding
- Teva Pharmaceutical Industries Ltd
Highlights of The Inhaler Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Metered Dose Inhaler (MDI)
- Dry Powder Inhaler (DPI)
- Soft Mist Inhaler (SMI)
- By Application:
- Adults
- Children
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Inhaler Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Inhaler devices are medical devices that help people breathe easier. They come in a variety of shapes and sizes, and can be used to treat a variety of conditions, such as asthma, COPD (chronic obstructive pulmonary disease), or allergies. Inhalers work by delivering an aerosolized medication directly into the lungs. This helps to open up the airways and improve breathing.
Some of the key players operating in the inhaler devices market are 3M, Bespak, Gerresheimer AG, Hovione, Iconovo AB, Adherium, Cohero Health, Trudell Medical International, Beximco Pharmaceuticals Ltd, Boehringer Ingelheim GmbH, Cipla Ltd, GSK, PARI Medical Holding, Teva Pharmaceutical Industries Ltd.
The inhaler devices market is expected to register a CAGR of 6.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Inhaler Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Inhaler Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Inhaler Devices Market - Supply Chain
4.5. Global Inhaler Devices Market Forecast
4.5.1. Inhaler Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Inhaler Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Inhaler Devices Market Absolute $ Opportunity
5. Global Inhaler Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Inhaler Devices Market Size and Volume Forecast by Type
5.3.1. Metered Dose Inhaler (MDI)
5.3.2. Dry Powder Inhaler (DPI)
5.3.3. Soft Mist Inhaler (SMI)
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Inhaler Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Inhaler Devices Market Size and Volume Forecast by Application
6.3.1. Adults
6.3.2. Children
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Inhaler Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Inhaler Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Inhaler Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Inhaler Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Inhaler Devices Demand Share Forecast, 2019-2029
9. North America Inhaler Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Inhaler Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Inhaler Devices Market Size and Volume Forecast by Application
9.4.1. Adults
9.4.2. Children
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Inhaler Devices Market Size and Volume Forecast by Type
9.7.1. Metered Dose Inhaler (MDI)
9.7.2. Dry Powder Inhaler (DPI)
9.7.3. Soft Mist Inhaler (SMI)
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Inhaler Devices Demand Share Forecast, 2019-2029
10. Latin America Inhaler Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Inhaler Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Inhaler Devices Market Size and Volume Forecast by Application
10.4.1. Adults
10.4.2. Children
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Inhaler Devices Market Size and Volume Forecast by Type
10.7.1. Metered Dose Inhaler (MDI)
10.7.2. Dry Powder Inhaler (DPI)
10.7.3. Soft Mist Inhaler (SMI)
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Inhaler Devices Demand Share Forecast, 2019-2029
11. Europe Inhaler Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Inhaler Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Inhaler Devices Market Size and Volume Forecast by Application
11.4.1. Adults
11.4.2. Children
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Inhaler Devices Market Size and Volume Forecast by Type
11.7.1. Metered Dose Inhaler (MDI)
11.7.2. Dry Powder Inhaler (DPI)
11.7.3. Soft Mist Inhaler (SMI)
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Inhaler Devices Demand Share, 2019-2029
12. Asia Pacific Inhaler Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Inhaler Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Inhaler Devices Market Size and Volume Forecast by Application
12.4.1. Adults
12.4.2. Children
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Inhaler Devices Market Size and Volume Forecast by Type
12.7.1. Metered Dose Inhaler (MDI)
12.7.2. Dry Powder Inhaler (DPI)
12.7.3. Soft Mist Inhaler (SMI)
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Inhaler Devices Demand Share, 2019-2029
13. Middle East & Africa Inhaler Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Inhaler Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Inhaler Devices Market Size and Volume Forecast by Application
13.4.1. Adults
13.4.2. Children
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Inhaler Devices Market Size and Volume Forecast by Type
13.7.1. Metered Dose Inhaler (MDI)
13.7.2. Dry Powder Inhaler (DPI)
13.7.3. Soft Mist Inhaler (SMI)
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Inhaler Devices Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Inhaler Devices Market: Market Share Analysis
14.2. Inhaler Devices Distributors and Customers
14.3. Inhaler Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. 3M
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Bespak
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Gerresheimer AG
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Hovione
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Iconovo AB
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Adherium
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Cohero Health
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Trudell Medical International
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Beximco Pharmaceuticals Ltd
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Boehringer Ingelheim GmbH
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Cipla Ltd
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. GSK
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. PARI Medical Holding
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Teva Pharmaceutical Industries Ltd
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook